Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Mounjaro pen still has some liquid in it after you've injected, that's completely normal. Every KwikPen is designed with a small amount of medicine beyond what you actually receive in the dose, and that excess stays in the pen by design — not because the injection failed or was incomplete. Read on for what the leftover liquid actually is, and what to do with it. These are prescription-only medicines, so anything about your specific dose or technique should be confirmed with your prescriber or pharmacist rather than assumed from general guidance.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You pressed the button, held it in place, heard the click, counted to ten as the leaflet says, and then you looked at the pen and there it was: a small window of liquid still sitting there. It's unsettling, especially when you're new to this. You might wonder whether the medicine went in at all.
It did. The Mounjaro KwikPen works by pushing a pre-set volume of tirzepatide through the needle when the button is fully depressed. That volume is fixed by the device, not by how much liquid you can see. What remains after injection is a manufacturing overfill (a standard feature of pre-filled injection pens across many medicines) that ensures the full therapeutic dose is always delivered even with small variability in the device. The pen's plunger physically cannot push past its set point, so the overfill stays behind. You can read more about how the KwikPen works on our Mounjaro injection guide.
The NHS patient information for tirzepatide notes that a small amount of solution remaining in the pen after injection is expected and is not a sign that the dose was incomplete. This is consistent with the product's Summary of Product Characteristics published on the eMC.
This is the question our prescribers hear fairly often, and the answer is an unambiguous no. Once the KwikPen has delivered its dose and locked, it is finished. Attempting a second injection from the same pen carries real risks: the volume remaining is not a full dose, the needle has already been used and should not re-enter skin, and the device is not designed to function reliably for a second attempt. Any second press could deliver a fraction of the normal dose, leading to unpredictable absorption, not nothing, but not the right amount either.
There's also a contamination point. A used needle can draw biological material back into the pen body. Pharmacy guidance is consistent: used pens go in a sharps bin, regardless of visible residual liquid. If you're curious about why some pens appear to have more residual than others, that's worth reading before your next injection.
The waste feels real (these pens aren't cheap) but trying to extract or reuse the remainder creates a safety problem rather than solving an economic one. A transparent conversation about cost, including what a properly supervised private prescription actually includes, is on our Mounjaro private prescription page.
Pre-filled medicine pens are filled to a nominal volume that slightly exceeds the labelled dose. Manufacturers do this deliberately so that, even with minor variability in how the device seats or how air is managed inside the pen, you still receive the full prescribed amount. It's the same principle behind why a bottle of medicine might contain a small buffer above the labelled dose count.
For Mounjaro specifically, the pen contains tirzepatide in a solution; what you see in the viewing window is that solution. The dose you received left through the needle. What's left behind is the overfill, which serves its purpose the moment it ensures the plunger could travel its full stroke without running dry. There's no meaningful way to estimate exactly how much remains, and trying to do so is not a useful exercise. The visible liquid in the Mounjaro pen is a design feature, not a warning sign.
If you want to understand the full picture of how Mounjaro works (mechanism, dosing schedule, what clinical trials showed) that overview covers it properly, with sources.
Once you've confirmed your injection is complete (button fully pressed, ten-second hold, pen removed from skin) the pen should go straight into a sharps container. A used needle sitting uncapped is a sharps hazard for anyone else in the household, and standard household bins don't accept clinical waste. Local authorities typically collect sealed sharps bins; your pharmacist can also advise on return schemes.
A few things worth checking at your next injection, not for the current dose but as a habit: rotate your injection site each time (abdomen, outer thigh and upper arm are the three options), use a fresh needle every time, and clean the skin with an alcohol swab before injecting. These steps don't affect the residual liquid question, but they are the ones most likely to affect how comfortable and consistent your injections feel over time.
If anything about your pen looked genuinely unusual (the plunger didn't move, the button stuck, the liquid looked cloudy or discoloured) that's a conversation for your prescriber rather than something to troubleshoot alone. The range of reasons liquid remains in the pen covers the normal variation; a device fault is a different matter entirely. You can also explore weight management treatment options more broadly if you're at an earlier stage of thinking this through.
If you're not yet on Mounjaro and this page came up while you were researching the process, check your eligibility with our prescribers, consultations are free and reviewed the same day by a named GPhC-registered prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.